tiprankstipranks
Advertisement
Advertisement

AU:LTP Stock Latest News

LTR Pharma Seeks ASX Quotation for Additional Ordinary Shares
Company AnnouncementsLTR Pharma Seeks ASX Quotation for Additional Ordinary Shares
3d ago
LTP
LTR Pharma outlines specialty therapy focus and restricts investor presentation use
PremiumCompany Announcements
LTR Pharma outlines specialty therapy focus and restricts investor presentation use
5d ago
LTP
LTR Pharma moves into oral testosterone with KYZATREX pilot deal
PremiumCompany Announcements
LTR Pharma moves into oral testosterone with KYZATREX pilot deal
7d ago
LTP
LTR Pharma Issues Unquoted Performance Rights Under Employee Incentive Scheme
PremiumCompany Announcements
LTR Pharma Issues Unquoted Performance Rights Under Employee Incentive Scheme
2M ago
LTP
LTR Pharma Wins Ethics Nod for First GI Trial of Intranasal OROFLOW
PremiumCompany Announcements
LTR Pharma Wins Ethics Nod for First GI Trial of Intranasal OROFLOW
3M ago
LTP
LTR Pharma sets first U.S. telehealth route to market for ROXUS
PremiumCompany AnnouncementsLTR Pharma sets first U.S. telehealth route to market for ROXUS
3M ago
LTP
LTR Pharma outlines limits and legal caveats in latest investor update
Premium
Company Announcements
LTR Pharma outlines limits and legal caveats in latest investor update
4M ago
LTP
LTR Pharma Halts Trading Ahead of Interim SPONTAN Nasal Spray Trial Results
Premium
Company Announcements
LTR Pharma Halts Trading Ahead of Interim SPONTAN Nasal Spray Trial Results
4M ago
LTP
LTR Pharma advances SPONTAN Phase II study and U.S. ED spray strategy
PremiumCompany Announcements
LTR Pharma advances SPONTAN Phase II study and U.S. ED spray strategy
4M ago
LTP
LTR Pharma issues cautionary investor update on non-offer presentation
PremiumCompany Announcements
LTR Pharma issues cautionary investor update on non-offer presentation
6M ago
LTP
LTR Pharma completes recruitment for key Phase II SPONTAN study
PremiumCompany Announcements
LTR Pharma completes recruitment for key Phase II SPONTAN study
6M ago
LTP
LTR Pharma lodges half-year Appendix 4D report with ASX
PremiumCompany Announcements
LTR Pharma lodges half-year Appendix 4D report with ASX
6M ago
LTP
LTR Pharma Seeks ASX Quotation for Additional 50,000 Shares
PremiumCompany AnnouncementsLTR Pharma Seeks ASX Quotation for Additional 50,000 Shares
7M ago
LTP
LTR Pharma Advances ED Nasal Spray Programs as SPONTAN Use Tops 1,000 Prescriptions
Premium
Company Announcements
LTR Pharma Advances ED Nasal Spray Programs as SPONTAN Use Tops 1,000 Prescriptions
7M ago
LTP
LTR Pharma Begins Phase II Dosing for Intranasal Erectile Dysfunction Spray SPONTAN
Premium
Company Announcements
LTR Pharma Begins Phase II Dosing for Intranasal Erectile Dysfunction Spray SPONTAN
8M ago
LTP
LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares
PremiumCompany Announcements
LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares
8M ago
LTP
LTR Pharma Issues 8.3 Million Unquoted Options Expiring in 2028
PremiumCompany Announcements
LTR Pharma Issues 8.3 Million Unquoted Options Expiring in 2028
8M ago
LTP
LTR Pharma Begins Phase II Recruitment for Intranasal Erectile Dysfunction Spray SPONTAN
PremiumCompany Announcements
LTR Pharma Begins Phase II Recruitment for Intranasal Erectile Dysfunction Spray SPONTAN
8M ago
LTP
LTR Pharma’s SPONTAN Nasal Spray Data Wins Podium Slot at 2026 Sexual Medicine Congress
PremiumCompany Announcements
LTR Pharma’s SPONTAN Nasal Spray Data Wins Podium Slot at 2026 Sexual Medicine Congress
8M ago
LTP
LTR Pharma Issues New Unquoted Performance Rights and Options Under Incentive Schemes
PremiumCompany AnnouncementsLTR Pharma Issues New Unquoted Performance Rights and Options Under Incentive Schemes
9M ago
LTP
LTR Pharma Achieves Milestone with SPONTAN® Prescriptions
Premium
Company Announcements
LTR Pharma Achieves Milestone with SPONTAN® Prescriptions
9M ago
LTP
LTR Pharma Receives TGA Clearance for SPONTAN® Phase II Study
Premium
Company Announcements
LTR Pharma Receives TGA Clearance for SPONTAN® Phase II Study
9M ago
LTP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >